Infective Endocarditis Following Transcatheter Aortic Valve Replacement and Cardiac Implantable Electronic Device

Lauge Østergaard; Nana Køber; Christian Tuxen; Thomas Sehestedt; Nis Høst; Lars Søndergaard; Jawad H. Butt; Eva Havers-Borgersen; Jeppe Kofoed Petersen; Andreas Dalsgaard Jensen; Gunnar Gislason; Christian Torp-Pedersen; Lars Køber; Emil L. Fosbøl

doi:10.1016/j.jcin.2021.04.053

Infective Endocarditis Following Transcatheter Aortic Valve Replacement and Cardiac Implantable Electronic Device

Lauge Østergaard^*, Nana Køber, Christian Tuxen, Thomas Sehestedt, Nis Høst, Lars Søndergaard, Jawad H. Butt, Eva Havers-Borgersen, Jeppe Kofoed Petersen, Andreas Dalsgaard Jensen, Gunnar Gislason, Christian Torp-Pedersen, Lars Køber, Emil L. Fosbøl

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Research › peer-review

2 Citations (Scopus)

Original language	English
Journal	JACC: Cardiovascular Interventions
Volume	14
Issue number	13
Pages (from-to)	1503-1505
Number of pages	3
ISSN	1936-8798
DOIs	https://doi.org/10.1016/j.jcin.2021.04.053
Publication status	Published - 12 Jul 2021

Access to Document

10.1016/j.jcin.2021.04.053

Cite this

Østergaard, L., Køber, N., Tuxen, C., Sehestedt, T., Høst, N., Søndergaard, L., Butt, J. H., Havers-Borgersen, E., Petersen, J. K., Jensen, A. D., Gislason, G., Torp-Pedersen, C., Køber, L., & Fosbøl, E. L. (2021). Infective Endocarditis Following Transcatheter Aortic Valve Replacement and Cardiac Implantable Electronic Device. JACC: Cardiovascular Interventions, 14(13), 1503-1505. https://doi.org/10.1016/j.jcin.2021.04.053

Infective Endocarditis Following Transcatheter Aortic Valve Replacement and Cardiac Implantable Electronic Device. / Østergaard, Lauge; Køber, Nana; Tuxen, Christian; Sehestedt, Thomas; Høst, Nis; Søndergaard, Lars; Butt, Jawad H.; Havers-Borgersen, Eva; Petersen, Jeppe Kofoed; Jensen, Andreas Dalsgaard; Gislason, Gunnar ; Torp-Pedersen, Christian ; Køber, Lars; Fosbøl, Emil L.

In: JACC: Cardiovascular Interventions, Vol. 14, No. 13, 12.07.2021, p. 1503-1505.

Research output: Contribution to journal › Letter › Research › peer-review

Østergaard, L, Køber, N, Tuxen, C, Sehestedt, T, Høst, N, Søndergaard, L, Butt, JH, Havers-Borgersen, E, Petersen, JK, Jensen, AD, Gislason, G , Torp-Pedersen, C , Køber, L & Fosbøl, EL 2021, 'Infective Endocarditis Following Transcatheter Aortic Valve Replacement and Cardiac Implantable Electronic Device', JACC: Cardiovascular Interventions, vol. 14, no. 13, pp. 1503-1505. https://doi.org/10.1016/j.jcin.2021.04.053

Østergaard, Lauge ; Køber, Nana ; Tuxen, Christian ; Sehestedt, Thomas ; Høst, Nis ; Søndergaard, Lars ; Butt, Jawad H. ; Havers-Borgersen, Eva ; Petersen, Jeppe Kofoed ; Jensen, Andreas Dalsgaard ; Gislason, Gunnar ; Torp-Pedersen, Christian ; Køber, Lars ; Fosbøl, Emil L. / Infective Endocarditis Following Transcatheter Aortic Valve Replacement and Cardiac Implantable Electronic Device. In: JACC: Cardiovascular Interventions. 2021 ; Vol. 14, No. 13. pp. 1503-1505.

@article{72b8e3d8a8624063a63f37a603b05b25,

title = "Infective Endocarditis Following Transcatheter Aortic Valve Replacement and Cardiac Implantable Electronic Device",

author = "Lauge {\O}stergaard and Nana K{\o}ber and Christian Tuxen and Thomas Sehestedt and Nis H{\o}st and Lars S{\o}ndergaard and Butt, {Jawad H.} and Eva Havers-Borgersen and Petersen, {Jeppe Kofoed} and Jensen, {Andreas Dalsgaard} and Gunnar Gislason and Christian Torp-Pedersen and Lars K{\o}ber and Fosb{\o}l, {Emil L.}",

note = "Funding Information: Dr. S{\o}ndergaard has received consultant fees and/or institutional research grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, Novo Nordisk, SMT, and Symetis. Dr. Torp-Pedersen has received research grants from Bayer and Novo Nordisk. Dr. K{\o}ber has received speakers fees from Novo Nordisk, Novartis, Boehringer Ingelheim, and AstraZeneca unrelated to this work. Dr. Fosb{\o}l has received an independent research grant from Novo Nordisk. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Dr. S?ndergaard has received consultant fees and/or institutional research grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, Novo Nordisk, SMT, and Symetis. Dr. Torp-Pedersen has received research grants from Bayer and Novo Nordisk. Dr. K?ber has received speakers fees from Novo Nordisk, Novartis, Boehringer Ingelheim, and AstraZeneca unrelated to this work. Dr. Fosb?l has received an independent research grant from Novo Nordisk. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.",

year = "2021",

month = jul,

day = "12",

doi = "10.1016/j.jcin.2021.04.053",

language = "English",

volume = "14",

pages = "1503--1505",

journal = "J A C C: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier",

number = "13",

}

TY - JOUR

T1 - Infective Endocarditis Following Transcatheter Aortic Valve Replacement and Cardiac Implantable Electronic Device

AU - Østergaard, Lauge

AU - Køber, Nana

AU - Tuxen, Christian

AU - Sehestedt, Thomas

AU - Høst, Nis

AU - Søndergaard, Lars

AU - Butt, Jawad H.

AU - Havers-Borgersen, Eva

AU - Petersen, Jeppe Kofoed

AU - Jensen, Andreas Dalsgaard

AU - Gislason, Gunnar

AU - Torp-Pedersen, Christian

AU - Køber, Lars

AU - Fosbøl, Emil L.

N1 - Funding Information: Dr. Søndergaard has received consultant fees and/or institutional research grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, Novo Nordisk, SMT, and Symetis. Dr. Torp-Pedersen has received research grants from Bayer and Novo Nordisk. Dr. Køber has received speakers fees from Novo Nordisk, Novartis, Boehringer Ingelheim, and AstraZeneca unrelated to this work. Dr. Fosbøl has received an independent research grant from Novo Nordisk. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Dr. S?ndergaard has received consultant fees and/or institutional research grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, Novo Nordisk, SMT, and Symetis. Dr. Torp-Pedersen has received research grants from Bayer and Novo Nordisk. Dr. K?ber has received speakers fees from Novo Nordisk, Novartis, Boehringer Ingelheim, and AstraZeneca unrelated to this work. Dr. Fosb?l has received an independent research grant from Novo Nordisk. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2021/7/12

Y1 - 2021/7/12

U2 - 10.1016/j.jcin.2021.04.053

DO - 10.1016/j.jcin.2021.04.053

M3 - Letter

C2 - 34238563

AN - SCOPUS:85108724874

VL - 14

SP - 1503

EP - 1505

JO - J A C C: Cardiovascular Interventions

JF - J A C C: Cardiovascular Interventions

SN - 1936-8798

IS - 13

ER -